Funds and ETFs Jubilant Pharmova Limited

Equities

JUBLPHARMA

INE700A01033

Pharmaceuticals

Delayed Bombay S.E. 01:28:08 2024-04-29 am EDT 5-day change 1st Jan Change
685.6 INR +0.72% Intraday chart for Jubilant Pharmova Limited +0.65% +25.63%

ETFs positioned on Jubilant Pharmova Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.00% 34 M€ +2.14% -
0.00% 117 M€ +1.11% -
Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company's segments include Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six manufacturing facilities in India, United States and Canada and a network of approximately 48 radio pharmacies in the United States. The Contract Research and Development Services segment provides drug discovery and development services as well as clinical data software and service solutions. The Proprietary Novel Drugs segment is a patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.
More about the company
  1. Stock Market
  2. Equities
  3. JUBLPHARMA Stock
  4. Funds and ETFs Jubilant Pharmova Limited